Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles - PubMed
- ️Wed Jan 01 1992
Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
Y Yin et al. Cell. 1992.
Abstract
Loss of cell cycle control and acquisition of chromosomal rearrangements such as gene amplification often occur during tumor progression, suggesting that they may be correlated. We show here that the wild-type p53 allele is lost when fibroblasts from patients with the Li-Fraumeni syndrome (LFS) are passaged in vitro. Normal and LFS cells containing wild-type p53 arrested in G1 when challenged with the uridine biosynthesis inhibitor PALA and did not undergo PALA-selected gene amplification. The converse occurred in cells lacking wild-type p53 expression. Expression of wild-type p53 in transformants of immortal and tumor cells containing mutant p53 alleles restored G1 control and reduced the frequency of gene amplification to undetectable levels. These studies reveal that p53 contributes to a metabolically regulated G1 check-point, and they provide a model for understanding how abnormal cell cycle progression leads to the genetic rearrangements involved in tumor progression.
Similar articles
-
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.
Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD. Livingstone LR, et al. Cell. 1992 Sep 18;70(6):923-35. doi: 10.1016/0092-8674(92)90243-6. Cell. 1992. PMID: 1356076
-
Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations.
Liu PK, Kraus E, Wu TA, Strong LC, Tainsky MA. Liu PK, et al. Oncogene. 1996 Jun 6;12(11):2267-78. Oncogene. 1996. PMID: 8649766 Free PMC article.
-
Cell cycle arrest defect in Li-Fraumeni Syndrome: a mechanism of cancer predisposition?
Williams KJ, Boyle JM, Birch JM, Norton JD, Scott D. Williams KJ, et al. Oncogene. 1997 Jan 23;14(3):277-82. doi: 10.1038/sj.onc.1200838. Oncogene. 1997. PMID: 9018113
-
Genomic integrity and the genetics of cancer.
Tlsty TD, White A, Livanos E, Sage M, Roelofs H, Briot A, Poulose B. Tlsty TD, et al. Cold Spring Harb Symp Quant Biol. 1994;59:265-75. doi: 10.1101/sqb.1994.059.01.031. Cold Spring Harb Symp Quant Biol. 1994. PMID: 7587078 Review. No abstract available.
-
[p53 transgenic and knockout mice].
Oda H. Oda H. Nihon Rinsho. 2000 Jun;58(6):1250-4. Nihon Rinsho. 2000. PMID: 10879049 Review. Japanese.
Cited by
-
Lindel K, Rieken S, Daffinger S, Weber KJ, de Villiers EM, Debus J. Lindel K, et al. Radiat Oncol. 2012 Nov 7;7:187. doi: 10.1186/1748-717X-7-187. Radiat Oncol. 2012. PMID: 23134732 Free PMC article.
-
Kopnin PB, Agapova LS, Kopnin BP, Chumakov PM. Kopnin PB, et al. Cancer Res. 2007 May 15;67(10):4671-8. doi: 10.1158/0008-5472.CAN-06-2466. Cancer Res. 2007. PMID: 17510393 Free PMC article.
-
Overholtzer M, Rao PH, Favis R, Lu XY, Elowitz MB, Barany F, Ladanyi M, Gorlick R, Levine AJ. Overholtzer M, et al. Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11547-52. doi: 10.1073/pnas.1934852100. Epub 2003 Sep 12. Proc Natl Acad Sci U S A. 2003. PMID: 12972634 Free PMC article.
-
Guo HY, Hoffman RM, Herrera H. Guo HY, et al. In Vitro Cell Dev Biol Anim. 1993 May;29A(5):359-61. doi: 10.1007/BF02633982. In Vitro Cell Dev Biol Anim. 1993. PMID: 8314730 No abstract available.
-
TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material.
Gretarsdottir S, Tryggvadottir L, Jonasson JG, Sigurdsson H, Olafsdottir K, Agnarsson BA, Ogmundsdottir H, Eyfjörd JE. Gretarsdottir S, et al. Br J Cancer. 1996 Aug;74(4):555-61. doi: 10.1038/bjc.1996.400. Br J Cancer. 1996. PMID: 8761369 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous